{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:47:30Z","timestamp":1794368850965,"version":"4.9.0"},"reference-count":33,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000896","name":"Coleman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    We investigated the outcomes of patients with advanced systemic mastocytosis (AdvSM) undergoing allogeneic haematopoietic cell therapy (alloHCT) in the US. Twenty\u2010seven adult (median age, 58\u2009years) patients with AdvSM received alloHCT from 2014 to 2021. Most patients were white (93%), male (63%) and had systemic mastocytosis (SM) with associated haematological neoplasm (SM\u2010AHN, 70%), received peripheral blood grafts (89%) and non\u2010myeloablative regimens.\n                    <jats:italic>KIT<\/jats:italic>\n                    mutation was detected in 14 of the reported 16 patients (87.5%). Post\u2010transplantation cyclophosphamide (PTCy) was used in approximately 50% of the cohort. Approximately 1\u2009year after alloHCT, median bone marrow mast cell burden decreased from 15% pre\u2010alloHCT to 1.5% (range 0\u20138) at 1\u2009year post\u2010alloHCT. The median serum tryptase decreased from 55\u2009ng\/mL (range 3\u2013400\u2009ng\/mL) pre\u2010alloHCT to 18\u2009ng\/mL (range 0\u2013481\u2009ng\/mL) at 1\u2009year post\u2010alloHCT. At 1\u2009year, progression\u2010free survival (PFS) and overall survival (OS) were 59% (95% confidence interval [CI], 41%\u201377%) and 74% (95% CI, 56%\u201389%) respectively. In the subset of patients with SM\u2010AHN, 1\u2010year PFS and OS were 74% (52%\u201391%) and 79% (95% CI, 58%\u201394%) respectively. The cumulative incidence of relapse\/progression for the entire population of patients with SM (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200927) was 4% (95% CI, 0\u201314) at 100\u2009days and 15% (95% CI, 4\u201331) at 1\u2009year. For the subset of patients with AHN, the cumulative incidence was 11% (95% CI, 1\u201328) at 100\u2009days and 21% (95% CI, 6\u201342) at 1\u2009year. Relapse\/progression was the cause of death in six of 12 patients (5 died of AHN and 1 died of SM progression). Eighteen and nine patients received a KIT inhibitor before alloHCT and after alloHCT respectively. In addition, six patients received a KIT inhibitor for the treatment of relapse\/progression of SM after alloHCT. Although it is difficult to delineate the exact effect of alloHCT and KIT inhibitors because of the size of the study in this era, the use of alloHCT and KIT inhibitors pre\u2010 and post\u2010 alloHCT is increasing. In the near future, larger studies are required to provide further insights into this subject.\n                  <\/jats:p>","DOI":"10.1111\/bjh.70154","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:39:28Z","timestamp":1758591568000},"page":"2486-2495","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A\n                    <scp>CIBMTR<\/scp>\n                    study"],"prefix":"10.1111","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-6213","authenticated-orcid":false,"given":"Celalettin","family":"Ustun","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology\/Cell Therapy, Department of Medicine Rush University  Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei\u2010Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"CIBMTR\u00ae (Center for International Blood and Marrow Transplant Research) Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Peterson","sequence":"additional","affiliation":[{"name":"CIBMTR\u00ae (Center for International Blood and Marrow Transplant Research) Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Baek","sequence":"additional","affiliation":[{"name":"CIBMTR\u00ae (Center for International Blood and Marrow Transplant Research) Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounzer","family":"Agha","sequence":"additional","affiliation":[{"name":"UPMC Hillman Cancer Center  Pittsburgh Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3609-8404","authenticated-orcid":false,"given":"Hassan","family":"Alkhateeb","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Chhabra","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine Mayo Clinic  Phoenix Arizona USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Coltoff","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine MUSC  Charleston South Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"de Lima","sequence":"additional","affiliation":[{"name":"The James Comprehensive Cancer Center, Division of Hematology The Ohio State University  Columbus Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute Oregon Health &amp; Science University  Oregon Portland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ho","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Department of Medical Oncology Dana\u2010Farber Cancer Institute, Harvard Medical School  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adetola","family":"Kassim","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine Vanderbilt University Medical Center  Nashville Tennessee USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine Northwestern Memorial Hospital  Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lohith","family":"Gowda","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplantation Yale University School of Medicine  New Haven Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7679-6453","authenticated-orcid":false,"given":"Gautam","family":"Borthakur","sequence":"additional","affiliation":[{"name":"Department of Leukemia University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"DeAngelo","sequence":"additional","affiliation":[{"name":"Division of Leukemia Dana\u2010Farber Cancer Institute  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"McGuirk","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Cellular Therapeutics University of Kansas Medical Center  Kansas City Kansas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Mensah","sequence":"additional","affiliation":[{"name":"Hematology and Medical Oncology, Hematology, Medical Oncology, Fransciscan Health  Mishawaka Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9625-1178","authenticated-orcid":false,"given":"Kalyan V.","family":"Nadiminti","sequence":"additional","affiliation":[{"name":"Carbone Cancer Center, Division of Hematology, Medical Oncology and Palliative Care University of Wisconsin  Madison Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2621-7924","authenticated-orcid":false,"given":"Taiga","family":"Nishihori","sequence":"additional","affiliation":[{"name":"Department of Blood &amp; Marrow Transplant and Cellular Immunotherapy (BMT CI) Moffitt Cancer Center  Tampa Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Pantin","sequence":"additional","affiliation":[{"name":"The Sarah Cannon Transplant and Cellular Therapy Program, TriStar Centennial Medical Center  Nashville Tennessee USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8961-4639","authenticated-orcid":false,"given":"Andrew","family":"Trunk","sequence":"additional","affiliation":[{"name":"The University of Utah Transplant and Cellular Therapy Program  Salt Lake City Utah USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Uberti","sequence":"additional","affiliation":[{"name":"Karmanos Cancer Center, Hudson\u2010Webber Cancer Research Center  Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[{"name":"Department of Hematologic Malignancies Translational Science Beckman Research Institute of City of Hope  Monrovia California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Gotlib","sequence":"additional","affiliation":[{"name":"Division of Hematology Stanford University School of Medicine, Stanford Cancer Institute  Stanford California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Akin","sequence":"additional","affiliation":[{"name":"Division of Allergy and Clinical Immunology, Department of Medicine University of Michigan  Ann Arbor Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5372-510X","authenticated-orcid":false,"given":"Mehdi","family":"Hamadani","sequence":"additional","affiliation":[{"name":"CIBMTR\u00ae (Center for International Blood and Marrow Transplant Research) Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Pullarkat","sequence":"additional","affiliation":[{"name":"Department of Hematologic Malignancies Translational Science Beckman Research Institute of City of Hope  Monrovia California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[{"name":"Division of Hematology &amp; Hemostaseology, Department of Internal Medicine I, and Ludwig Boltzmann Cluster Oncology Medical University of Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Grunwald","sequence":"additional","affiliation":[{"name":"Department of Hematologic Oncology and Blood Disorders Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine  Charlotte North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Juckett","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation University of Minnesota  Minneapolis Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1264-5968","authenticated-orcid":false,"given":"Betul","family":"Oran","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Saber","sequence":"additional","affiliation":[{"name":"CIBMTR\u00ae (Center for International Blood and Marrow Transplant Research) Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda J.","family":"Burns","sequence":"additional","affiliation":[{"name":"CIBMTR\u00ae (Center for International Blood and Marrow Transplant Research) Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"issue":"11","key":"e_1_2_9_2_1","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent P","year":"2021","journal-title":"Hema"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-205237"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2024.08.044"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2023.04.011"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015125"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30166-8"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.72"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2677"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.146563"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008038"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15913"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1513098"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01538-9"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.2018"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02186-x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.9.2954.2954"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.198"},{"issue":"6","key":"e_1_2_9_19_1","article-title":"Discordant response of systemic Mastocytosis associated with myelodysplastic syndrome after midostaurin and allogeneic hematopoietic stem\u2010cell transplantation","volume":"4","author":"Haas M","year":"2020","journal-title":"Hema"},{"key":"e_1_2_9_20_1","first-page":"699","article-title":"Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee","volume":"38","author":"McLornan DP","year":"2024","journal-title":"Leukemia"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.04.018"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01615-z"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01771"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.05.002"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-023-02131-z"},{"issue":"6","key":"e_1_2_9_26_1","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka D","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.12.001"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215943"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2023.103398"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-180275"},{"issue":"5","key":"e_1_2_9_31_1","first-page":"413","article-title":"Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome","volume":"8","author":"Ronnov\u2010Jessen D","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704627"},{"key":"e_1_2_9_33_1","doi-asserted-by":"crossref","unstructured":"ReiterA GotlibJ RadiaD DeiningerM GeorgeT PanseJ et\u00a0al.Avapritinib in patients with advanced systemic mastocytosis (Advsm): efficacy and safety analysis from the phase 2 pathfinder study with 3\u2010year follow\u2010up. European Hematology Association Annual Meeting2024.","DOI":"10.1097\/01.HS9.0000970992.31848.76"},{"issue":"9","key":"e_1_2_9_34_1","first-page":"2048","article-title":"Systemic mastocytosis: current status and challenges in 2024","volume":"9","author":"Ustun C","year":"2025","journal-title":"Blood Adv"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T11:44:17Z","timestamp":1767959057000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.70154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1111\/bjh.70154"],"URL":"https:\/\/doi.org\/10.1111\/bjh.70154","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"2025-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}